BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33493455)

  • 1. Application of high-throughput gene sequencing in lymphoma.
    Lv X; Wang Q; Ge X; Xue C; Liu X
    Exp Mol Pathol; 2021 Apr; 119():104606. PubMed ID: 33493455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic studies on lymphoma].
    Yamaguchi K; Kataoka K
    Rinsho Ketsueki; 2021; 62(8):1121-1130. PubMed ID: 34497199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.
    Slack GW
    Surg Pathol Clin; 2023 Jun; 16(2):433-442. PubMed ID: 37149368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
    Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
    Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of molecular biology in the diagnosis of lymphoid neoplasms.
    Pizzi M; Gazzola A; Mannu C; Pileri SA; Sabattini E; Pileri SA
    Front Biosci (Landmark Ed); 2014 Jun; 19(7):1088-104. PubMed ID: 24896338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
    Ohshima K; Suzumiya J; Kikuchi M
    Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic dissection of the molecular mechanism of malignant lymphoma using advanced genomic technology].
    Shingaki S; Kataoka K
    Rinsho Ketsueki; 2022; 63(9):1058-1066. PubMed ID: 36198530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
    Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
    Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond.
    Rosenquist R; Rosenwald A; Du MQ; Gaidano G; Groenen P; Wotherspoon A; Ghia P; Gaulard P; Campo E; Stamatopoulos K;
    Haematologica; 2016 Sep; 101(9):1002-9. PubMed ID: 27582569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications of next-generation sequencing in non-Hodgkin's lymphoma.
    Heimann P; Dewispelaere L
    Curr Opin Oncol; 2020 Sep; 32(5):391-397. PubMed ID: 32675596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome sequencing of lymphoid malignancies.
    Mullighan CG
    Blood; 2013 Dec; 122(24):3899-907. PubMed ID: 24041576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.
    Guillermin Y; Lopez J; Chabane K; Hayette S; Bardel C; Salles G; Sujobert P; Huet S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29677173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life targeted next-generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network.
    Bommier C; Mauduit C; Fontaine J; Bourbon E; Sujobert P; Huet S; Baseggio L; Hayette S; Laurent C; Bachy E; Ghesquières H; Thieblemont C; Salles G; Traverse-Glehen A
    Br J Haematol; 2021 Jun; 193(6):1110-1122. PubMed ID: 33764507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of genomic alterations in primary central nervous system lymphomas.
    Zorofchian S; El-Achi H; Yan Y; Esquenazi Y; Ballester LY
    J Neurooncol; 2018 Dec; 140(3):509-517. PubMed ID: 30171453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to lymphoma diagnosis.
    Harris NL; Stein H; Coupland SE; Hummel M; Favera RD; Pasqualucci L; Chan WC
    Hematology Am Soc Hematol Educ Program; 2001; ():194-220. PubMed ID: 11722985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-generation sequencing of cancer consensus genes in lymphoma.
    Hüllein J; Jethwa A; Stolz T; Blume C; Sellner L; Sill M; Langer C; Jauch A; Paruzynski A; von Kalle C; Schmidt M; Glimm H; Zenz T
    Leuk Lymphoma; 2013 Aug; 54(8):1831-5. PubMed ID: 23621802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of B-cell lymphomas: diagnosis and biomarker discovery.
    Ondrejka SL; Hsi ED
    Cancer Treat Res; 2015; 165():27-50. PubMed ID: 25655605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic aberrations of signaling pathways in lymphomagenesis: revelations from next generation sequencing studies.
    Rossi D; Ciardullo C; Gaidano G
    Semin Cancer Biol; 2013 Dec; 23(6):422-30. PubMed ID: 23665546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.
    Jardin F
    Discov Med; 2014; 18(97):51-65. PubMed ID: 25091488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.